Drug Keytruda May Help Block Melanoma’s Return
MONDAY, April 16, 2018 (HealthDay News) — Taking the drug Keytruda after surgery for advanced melanoma significantly reduced patients’ risk of their cancer returning, a new study found. Last May, Keytruda (pembrolizumab) became the first ever drug approved by the U.S. Food and Drug Administration to fight cancers based onContinue Reading